Company Overview of AureoGen Biosciences, Inc.
AureoGen Biosciences, Inc. develops genetic engineering technologies for the discovery and production of cyclic peptide-based drugs. The company’s technologies also allow for the exploration of the pharmacological properties of various cyclic peptides, as well as the generation of cyclic peptides. AureoGen Biosciences, Inc. was founded in 2003 and is based in Kalamazoo, Michigan.
6475 Technology Avenue
Kalamazoo, MI 49009
Founded in 2003
Key Executives for AureoGen Biosciences, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
To contact AureoGen Biosciences, Inc., please visit www.aureogen.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.